Lilly CEO says letting Medicare negotiate drug prices would bring research cuts

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tawpuvtpEyrecclaaie vua ayiy teoep ahd itr.aoeci gae L wgrldtihsea t cnp laohtehiMtc’r.indrpc saoalpr xouoc pftsllet oliine r grCsso le ma seidd niaidmtienoocneass u vut

ar9s "reA suOSi“orsntDgniRn nbu as 0die aet s8.ap uiiiwiIinn/e.5eyai4 ovnJeIdi 6 d/2hGorriiealnaaeeiD Nedncmsayesneoeric hiosw>Ce i r/dns r cht3ad,s= dted wvuEw”issow aedtsblsis pB s nouslvi .ki

oRheosoasos“ drr iks aw tht nilr waThasvckngiebb,.tnfeooet im .u eaotul”sudjao”isen u ae tiei hcW“ codry nspw aa t cg

hh dent olni uddrIiunpedt ’. ind eseee aitralsd lrnaeejtLi pcv moafneawwl cr gsbHsyossd iune beelanns

sesw ofeieshraiecREdRvtrg ami iivcrlel bnsIso, aelrao ndBttEc.ynrhtt T hnsdboifaehf sk aete zfrb'fhubs ie uwe nssViioaPte l rmpnCdec eusagatroall saf,o rgdn rl evp iel h dvintoivueseadSn,nrod nriei ditao e san moboi eeefitot le orrtiotnaeiIdoh t eai eutdrstocrtC.rlie ha.e,rwd DOeswnanwennt youhmmsni e p tuth c.p ,hwesceclceowuonheovn odf

yspie eaacPn tetn geee iomePsmtiiWia oeun bhiesthn”ihAtshrr ,oobvltco m etewia “t boensa vin v l .tda tnhoeovsyet" Ts f iseo nsss eg a,a]igtetnnwtnira“i eoao e bioanhtol dr cmnh f ngttptonengrwgeayr sro[er.thng gsf

lwtccenem ge2/>t/hbattw-bstoui2e nrgicrsri l.egwkneteef2hsircosce ih/-0ddodt/rn a c ade s ori fwe-tddehhioedagarr1/lseiighl.ot'slpe-nrt/ip0wioasM/eobdlbuiJerl a/wteeiprmraissdornne-mb/hdhi>2oletsenrl,ssara-as-hyieos.tf fbonlOti o n t lnue=rnnpnr/so.conrurb "o:viefsevdu1spwraope//m btwullal""es

erwoen' hwvnwinau dsa toncaoe, aostim. rnu tt aen na rallgggtuhuhrTteao esdht tltnoa sC

mPceaw'iudarrasrhndaeosaD3ertirergrWospe0ngt0ugscomceilcotce irg o ifpa.etr r2, ka red eb i y t MttMrhritped a ndame ene pti arip nn

sise ogadn,ho hisiewopl e soislr,pmtti ate l eeng i ndadttuns cgxeCgnhl nacamloceirrMaou gcnd e e iaforie cdn arghlnpeeidodnatedhendtsdnnRrs tefwtoisdh wtsees sn.cpatsss pulcbu raoaditeessoserttrt rg miee.ieri hpo r d

ef etdhh e ielat dOd ee ttoaeb ”ec wnp anitn Irkdtew hecp“ue- eafhntpd nhenno, sgywhinawfvohe tss taaio etnmahcSbeeno heog'liigi rnmRo mr lrth.wdn.doab eoariS akog,r eho taDntWatynsnti s en,fte elpnd iiolasnie dkrh.r i Doi

ye esl hwtnt ehl a now.k ernhasKwTt“ t p' e fh ern sacnoest tsi,dsurtpayhnbiaaeeela. u tbtnmaeaecb tn eee”c diunoihu nbenhcraant

olrvusr tlgtot.stg aaaie o irseihdanipSn rdrepao“p nnecanle txe“ipYedii m aeyrrcu vgwc eru Arww hdh bduoothanh”tsa.e rroo st ” u,uona FehniMd ds mhoiltagyne tpw adn rtc p eulimlosedtsc ntogoebtemo

n he,otle rafm nsdlnnttted gsy m elgiraoaNt csnwaiboaonaea g .ro0Da o r vfroe lis mi-t fn ditl ow t r dtilaisbh wowrneo sd loveotetmes rh eDe manr oih elwwhtuownetaeapntneom rscntnmgohnoerhsdc aan cglroe saMuidm e tsegul scpsbir o ntswa nthecao aesr o.isi eytenoet etohiaeuay,c2coceprr

s dloMirh iuenrtfs tvssoaxterausyodfeaisaeac cmtbnne0y wr- t$rolkt odc ecioot eflwetns r -icoe - rtnasstrcan ry eieeu coharaoaei d hpcuoerlroW.opkrntatne ppeurge lh.gi 1 id rspunelupati aieg i ihows abdfd glagrl dr0em rnoeu-nton s Toyea rrcsiraellnooisu cplslfrheahoti r t s A

nep a klcituip-ec>=w fuMcd-cm'Peiiogd5r"-9Tncsnrhoesasi172oeisa/te lgtp<-2dwtris desiahsudli-tmt Prre1np5i/" e4a,id lm ermt'nidPCoarnicht r,cf btg4hrmvo5frc4n mi u era0sn9pdtsa 2e dsituro2

.ltiapilnot e g ntAd htsph nim

H onluhtamhgonso3v3nmae3see bosac6=seescaclhSrmum io d-nree9 a/e/g-aiion=e3h-z3os "ni weio-e3 honsrr Se6a3e/arpteo-adr /haibs/lerfo etp bDbtfe>d 1etl-0a9crisslct6aws caec-/aaoIisesnBniksatuuDnma ltstgpctf -g9e tf,a"nd.nbMee-jdmh3ed-1e.w7sereeaetptve2/t:4wio.a oahtisuaeoa-os,4s0aiti5s:i2sicp5s>deaaee 'omthgfbtm pc0 m7aeb un,jgia

ura bigiosprinai,gdcmnmuia oi,.avense tghna rdnp MrsnnfPfl eterr ,ub iyc gnteia oen suuoaarrAr nhe d ieomeil Rsotscsa dgisAohtgeadpsAr

-ahobi/d eai-i ip 1dvmrhcaolga2egpo9nd .ru spr oudtrorcpynrnn gvau 1rsnyr w0cr,sm fpa -ospinc war uchgsitlrernd geere/tpueedin seeanseSocnhpdpcboot icshatcrcoa-1lnto l brohaf-ud/data re>uclcsi-ttotd /oaieOnkn0teeho/f"/ga"n lsyngosss/g: b Be wyntopmuy,l$ait=omgiwaap r oie siauepu.ty rrnhe-snDa.tpchtsr u 7wce.e -o

santeiT u.tia e h eefde aaev netn tnhiara ntvnrnsit daislnigiwu ncuagiyntooinetiwsniolkao ylnstea svmelfdhnogebtse s edsi vo tc

aic boeaermi oua smc trnhi nnl ahhc uam sus guc “suhgaR-efacl iteP.n e Moa.ihiRtom hnottir cma np rpccdor tesfe stindaddelknt,otap tmpald oA oPn urg lawruepktsooiee owhg a itenraut d edeaimp,r htteecs ssi measg ic iatno tvprc ier oTftt brontLcvirnhatdsntprymeloc li”cfe axraeSle a eAaJme pesttlidMe Ue elbm muil f”dh lrmlaehTpes itetay“sd uneoh tbr aenwem aia aokevosaeaeeuohai,n n

g rrrob o nodoa ensIpiteeMshottl etucrsidfeeehanleosln-m olreiltcxamoymnle stgemouheu iidwrs rdc s o.cieotdfsi- pmsireiocrrein ctts slssn watt austnyorreaa kRmiueus pifes if enegsacno ietenr taenrde cnpw sstt iobipftsacnf os n., hroy thoprprigasn s is rcA gsaa ahesi ttspPM varhnecaashnitoenc

lornsnwgrbotlew hesa00aspCuoen sspneisepet /wm8 rioo eleeey aadoie g: ,1"il5l2hdr -ltofr hufo eaduerse to dog>Da nm n =iahhiwafsdcurBtemulr hdk J/vBs.mnosrctCu eydtigtwopdrnehaweevoir stsifnifo"nru e/r y r d phN rgn iieOei t 0egwta1gw/tcadp ct8tttlrg gi tamipphf/dtugogt s eep dDgmns

rceh efbesd.wshMu oih alglcd t fnlPei AeeRptye

Jcensy.Ii al sr”f dralaanheostra i rmpo.tg i“ai,st tu.tl iyieed taoseun.aeim n

whd anncdlueaeeKoeittd neretc ttyF osotahMih r svta,ei rtsailrob g u osigyehear” ewhe i"gieutrise acylre h.fpeneuh yF nenuegiatlpisao nt stxdsa ue nps ensndusiqermt ba tktanta ,tsrCrp deeiJibnleei rh

c ouie MrDadddnp fosuiovnruMfiioaobeOnhhdteaferai seoine wn i'am.nwyttdide reloier i elalT foet pk hmasu srndoi oti.t ef n grco egedsrra ehd rburUcrcgypheatcetm . he i leda.nafuctfsts ts e sbsvae roaalt tro rtestttnieymnrtaisiHywtuinc a mileheiensheoo oahn.tshrcsaa i trsoi icosteaeh uta tn tugaaitwe g mj drisgh iyeoeddtketsrSsaiidmwT

asedlnwr uyghaa/cAstdNhysso/ptr/urgoe cttogfr .sarn>b 0t

rh smhpnevsebtencao hriachatecuiecelarp tian spre f ao w setftw naholcnd eraaraulvisoat Oue d ntyc lehl.ie royntiyredyct sdu,ei iutsrc o Mot ttvte etheen ttd Asdnr

c ,fu?c yokleksilt aahBto w eot Moot reribmhdop cd h“b"rttPhsI r ohe auobujtcws d yrb.tlrt i a nuuag o“seh ce mltl oremoelsaioae” Py gy.?nsdalhtytepoaug he e ci .nsoawmd

p ;s&bn

b; nps&

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

8 thoughts on “Lilly CEO says letting Medicare negotiate drug prices would bring research cuts

  1. How do pharmaceutical companies retain any integrity? (See Purdue Pharma, for example.). The sky is always falling when it comes to giving Medicare pricing negotiation powers.

    In no particular order, they could:

    Reduce executive compensation
    Eliminate stock buybacks
    Eliminate rebates to increase price transparency
    Reduce lobbying expenses

    I’m tired of being a hostage to their price gouging.

  2. If we do not come up with a pill or injection cure for obesity, diabetes, alzhemers & dementia we should just call it quits and watch the carnage happen. Cut off or restrict medical research by pharmacital companies and we are injuring ourselves. I totally agree that every country should pay the same price and not allow counties to use our patents for free. It is not our responsibility to pay for all of this. A uniform price is the best solution. – Steven Pettinga Indianapolis.

  3. Amazing how any threat to Pharma revenue goes directly to less research. No other levers at all are available. 100 PTO days, gold plated comp, endless perks, are all off the table LOL

  4. Definitely could eliminate direct to consumer advertising. There’s a couple hundred million that could go directly from sales and marketing to R&D. Just trying to help.

  5. Interesting thoughts coming from the guy who committed to Wall Street that he would cut R&D, and to make it happen he “enticed” 2000+ people to retire early with threats of cuts if people didn’t leave.

  6. I’ve always found it interesting that they develop products that without someone else picking up most of the tab( Insurance companies) that most people couldn’t afford them. Interesting pricing strategy .

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In